Feng Mao Hua
Director/Board Member bei LEPU BIOPHARMA CO., LTD.
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Patrick Lu | M | 68 |
Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd.
 Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Sirnaomics, Inc., Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd. is a Chinese company that develops nucleic acid drugs. The private company is based in Suzhou, China. The company was founded in 2008 by Yang Lu, David Mark Evans. Yang Lu has been the CEO since 2008. | 16 Jahre |
| David Evans | M | 61 |
Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd.
Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Sirnaomics, Inc., Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd. is a Chinese company that develops nucleic acid drugs. The private company is based in Suzhou, China. The company was founded in 2008 by Yang Lu, David Mark Evans. Yang Lu has been the CEO since 2008. | 16 Jahre |
| Chen Mao | M | 61 | 16 Jahre | |
| Xiao Chang Dai | M | 61 |
Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd.
Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Sirnaomics, Inc., Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd. is a Chinese company that develops nucleic acid drugs. The private company is based in Suzhou, China. The company was founded in 2008 by Yang Lu, David Mark Evans. Yang Lu has been the CEO since 2008. | 3 Jahre |
| Jin Min Bai | M | 57 | 17 Jahre | |
| Cheung Hoi Yu | M | 69 |
Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd.
Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Sirnaomics, Inc., Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd. is a Chinese company that develops nucleic acid drugs. The private company is based in Suzhou, China. The company was founded in 2008 by Yang Lu, David Mark Evans. Yang Lu has been the CEO since 2008. | 3 Jahre |
| Yue Lei Shen | M | - | 15 Jahre | |
| Michael Vance Molyneaux | M | 54 |
Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd.
Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Sirnaomics, Inc., Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd. is a Chinese company that develops nucleic acid drugs. The private company is based in Suzhou, China. The company was founded in 2008 by Yang Lu, David Mark Evans. Yang Lu has been the CEO since 2008. | 3 Jahre |
| Ying Wu | M | 60 | 16 Jahre | |
| Xiang Rong Li | F | 51 |
Shanghai International Studies University
| 11 Jahre |
| Ho Sun | M | 54 | 18 Jahre | |
| Yu QifengY | M | 45 |
Shanghai NewMed Medical Co., Ltd.
 Shanghai NewMed Medical Co., Ltd. BiotechnologyHealth Technology Shanghai NewMed Medical Co., Ltd. engages in research, development, production of artificial heart valves and transcather implantation system. The company was founded by Yu QifengY in March 2015 and is headquartered in Shanghai, China. | 9 Jahre |
| Tao Qin | M | 51 |
Shanghai NewMed Medical Co., Ltd.
Shanghai NewMed Medical Co., Ltd. BiotechnologyHealth Technology Shanghai NewMed Medical Co., Ltd. engages in research, development, production of artificial heart valves and transcather implantation system. The company was founded by Yu QifengY in March 2015 and is headquartered in Shanghai, China. | 9 Jahre |
| Mo Nin Ung | F | 55 | - | |
| Delin Ren | M | 63 | 6 Jahre | |
| Lei Fu | M | 61 | 6 Jahre | |
| Xiaoxu Jiang | M | 52 |
Shanghai NewMed Medical Co., Ltd.
Shanghai NewMed Medical Co., Ltd. BiotechnologyHealth Technology Shanghai NewMed Medical Co., Ltd. engages in research, development, production of artificial heart valves and transcather implantation system. The company was founded by Yu QifengY in March 2015 and is headquartered in Shanghai, China. | 3 Jahre |
| Wing Kei Yip | M | 39 | 6 Jahre | |
| Yong Xiang Wang | M | 72 | 4 Jahre | |
| Xuyang Xie | M | 48 |
Shanghai NewMed Medical Co., Ltd.
Shanghai NewMed Medical Co., Ltd. BiotechnologyHealth Technology Shanghai NewMed Medical Co., Ltd. engages in research, development, production of artificial heart valves and transcather implantation system. The company was founded by Yu QifengY in March 2015 and is headquartered in Shanghai, China. | 8 Jahre |
| Hai Feng Yang | M | 47 | 4 Jahre | |
| De Min Zhou | M | 58 | 4 Jahre | |
| Jian Ni | M | - | - | |
| Michelle Chen | F | - |
BioSyngen Pte Ltd.
 BioSyngen Pte Ltd. Pharmaceuticals: MajorHealth Technology BioSyngen Pte Ltd. focuses on the clinical and commercial transfer of immune-cell therapy technologies and products. The company was founded in 2016 and is headquartered in Singapore. | - |
| Quan Yuan | M | - |
BioSyngen Pte Ltd.
BioSyngen Pte Ltd. Pharmaceuticals: MajorHealth Technology BioSyngen Pte Ltd. focuses on the clinical and commercial transfer of immune-cell therapy technologies and products. The company was founded in 2016 and is headquartered in Singapore. | - |
| Chang Yuan Yu | M | - | 4 Jahre | |
| Xia Yan Yang | F | 42 |
Shanghai NewMed Medical Co., Ltd.
Shanghai NewMed Medical Co., Ltd. BiotechnologyHealth Technology Shanghai NewMed Medical Co., Ltd. engages in research, development, production of artificial heart valves and transcather implantation system. The company was founded by Yu QifengY in March 2015 and is headquartered in Shanghai, China. | 3 Jahre |
| Yu Feng Zheng | M | 50 |
Shanghai NewMed Medical Co., Ltd.
Shanghai NewMed Medical Co., Ltd. BiotechnologyHealth Technology Shanghai NewMed Medical Co., Ltd. engages in research, development, production of artificial heart valves and transcather implantation system. The company was founded by Yu QifengY in March 2015 and is headquartered in Shanghai, China. | 3 Jahre |
| Mu Xian Sheng | F | - |
Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd.
Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Sirnaomics, Inc., Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd. is a Chinese company that develops nucleic acid drugs. The private company is based in Suzhou, China. The company was founded in 2008 by Yang Lu, David Mark Evans. Yang Lu has been the CEO since 2008. | - |
| Yun Yi Li | F | 44 | 4 Jahre | |
| Chao She Guo | M | - | 11 Jahre | |
| Meng Ying Huang | F | - |
Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd.
Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Sirnaomics, Inc., Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd. is a Chinese company that develops nucleic acid drugs. The private company is based in Suzhou, China. The company was founded in 2008 by Yang Lu, David Mark Evans. Yang Lu has been the CEO since 2008. | - |
| Zhong Jie Pu | M | 61 | 6 Jahre | |
| Patrick Sun | M | 66 | 3 Jahre | |
| Karen Eng | F | - |
CLSA Ltd.
 CLSA Ltd. Investment ManagersFinance CLSA Ltd. is the Hong Kong-based institutional brokerage subsidiary of CITIC Securities Co., Ltd. (SSE: 600030, SEHK: 6030), a full-service investment bank headquartered in China. Founded in 1986, the firm provides sales and execution services to global investors and corporates. | 20 Jahre |
| Stefano Domenicali | M | 59 | 3 Jahre | |
| Jia Wei Yao | M | 41 | 12 Jahre | |
| Hai Guang Wang | M | 60 | 6 Jahre | |
| Yung Hoi Tse | M | 71 | 10 Jahre | |
| Jiang Nan Cai | M | 67 |
Shanghai NewMed Medical Co., Ltd.
Shanghai NewMed Medical Co., Ltd. BiotechnologyHealth Technology Shanghai NewMed Medical Co., Ltd. engages in research, development, production of artificial heart valves and transcather implantation system. The company was founded by Yu QifengY in March 2015 and is headquartered in Shanghai, China. | 3 Jahre |
| Ziye Sui | M | - | 4 Jahre | |
| Xiao Yan Liang | F | 58 | 4 Jahre | |
| Mo Han Shing | F | 68 | - | |
| Yan Zhu | F | 60 | 13 Jahre | |
| Zhi Feng Long | M | 62 | - | |
| Liu Bin | M | - | 4 Jahre | |
| Yi Yang | M | - | 8 Jahre | |
| Jian Kang Zhang | M | - |
Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd.
Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Sirnaomics, Inc., Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd. is a Chinese company that develops nucleic acid drugs. The private company is based in Suzhou, China. The company was founded in 2008 by Yang Lu, David Mark Evans. Yang Lu has been the CEO since 2008. | - |
| Min Cong Huang | M | - |
Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd.
Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Sirnaomics, Inc., Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd. is a Chinese company that develops nucleic acid drugs. The private company is based in Suzhou, China. The company was founded in 2008 by Yang Lu, David Mark Evans. Yang Lu has been the CEO since 2008. | - |
| Xiantao Wen | M | 46 |
Shanghai NewMed Medical Co., Ltd.
Shanghai NewMed Medical Co., Ltd. BiotechnologyHealth Technology Shanghai NewMed Medical Co., Ltd. engages in research, development, production of artificial heart valves and transcather implantation system. The company was founded by Yu QifengY in March 2015 and is headquartered in Shanghai, China. | 7 Jahre |
| Lan Si Jiang | F | 57 | 1 Jahre | |
| Sabrina Wang | F | - | 5 Jahre | |
| John Buergenthal | M | - | - | |
| Xue Heng Cheng | M | 69 | 5 Jahre | |
| Xiao Yong Yu | M | 51 |
Shanghai NewMed Medical Co., Ltd.
Shanghai NewMed Medical Co., Ltd. BiotechnologyHealth Technology Shanghai NewMed Medical Co., Ltd. engages in research, development, production of artificial heart valves and transcather implantation system. The company was founded by Yu QifengY in March 2015 and is headquartered in Shanghai, China. | 3 Jahre |
| Xiu Lan Cheng | F | 45 |
Shanghai NewMed Medical Co., Ltd.
Shanghai NewMed Medical Co., Ltd. BiotechnologyHealth Technology Shanghai NewMed Medical Co., Ltd. engages in research, development, production of artificial heart valves and transcather implantation system. The company was founded by Yu QifengY in March 2015 and is headquartered in Shanghai, China. | 3 Jahre |
| Jie Zhang | M | 59 |
Shanghai NewMed Medical Co., Ltd.
Shanghai NewMed Medical Co., Ltd. BiotechnologyHealth Technology Shanghai NewMed Medical Co., Ltd. engages in research, development, production of artificial heart valves and transcather implantation system. The company was founded by Yu QifengY in March 2015 and is headquartered in Shanghai, China. | 9 Jahre |
| Kai Liu | M | 38 |
Shanghai NewMed Medical Co., Ltd.
Shanghai NewMed Medical Co., Ltd. BiotechnologyHealth Technology Shanghai NewMed Medical Co., Ltd. engages in research, development, production of artificial heart valves and transcather implantation system. The company was founded by Yu QifengY in March 2015 and is headquartered in Shanghai, China. | 3 Jahre |
| Lei Di Zhang | F | 44 | 2 Jahre | |
| Chun Li Sun | F | - | - | |
| Guo Wei Wang | M | 63 |
Shanghai NewMed Medical Co., Ltd.
Shanghai NewMed Medical Co., Ltd. BiotechnologyHealth Technology Shanghai NewMed Medical Co., Ltd. engages in research, development, production of artificial heart valves and transcather implantation system. The company was founded by Yu QifengY in March 2015 and is headquartered in Shanghai, China. | 4 Jahre |
| Min Cong Huang | M | 35 | 3 Jahre | |
| Zhi Xiong Ye | M | 63 | 6 Jahre | |
| Dmitry Samarsky | M | 57 | - | |
| Jacqueline A. Dombroski | M | - | - | |
| Yang Xu | M | 57 | 4 Jahre | |
| Qu An Zhang | M | 60 | - | |
| Siu Kuen Lai | F | 48 | 3 Jahre | |
| Francois Lebel | M | 72 | 1 Jahre | |
| Ming King Chiu | M | 47 |
Shanghai NewMed Medical Co., Ltd.
Shanghai NewMed Medical Co., Ltd. BiotechnologyHealth Technology Shanghai NewMed Medical Co., Ltd. engages in research, development, production of artificial heart valves and transcather implantation system. The company was founded by Yu QifengY in March 2015 and is headquartered in Shanghai, China. | 3 Jahre |
| Hing Ling Chau | F | 49 | 6 Jahre | |
| Ming Yang | M | 58 | 4 Jahre | |
| Victor Li Lietao | M | - |
BioSyngen Pte Ltd.
BioSyngen Pte Ltd. Pharmaceuticals: MajorHealth Technology BioSyngen Pte Ltd. focuses on the clinical and commercial transfer of immune-cell therapy technologies and products. The company was founded in 2016 and is headquartered in Singapore. | - |
| Lei Di Zhang | F | 43 | 2 Jahre | |
| Jue Pu | M | 34 | 4 Jahre | |
| Ting Cheung Leung | M | 41 | - | |
| Rongqiang Liu | M | 58 | 6 Jahre | |
| Maggie Geman Li | F | 58 | 4 Jahre | |
| Xiaoyu Fei | F | 36 | 6 Jahre | |
| Jian Kang Zhang | M | 67 | 3 Jahre | |
| Wai Ching Au | F | - | - | |
| Hai Chao Zhang | M | - | - | |
| Yan Li | F | - | - | |
| Zhang Qiong | F | - |
BioSyngen Pte Ltd.
BioSyngen Pte Ltd. Pharmaceuticals: MajorHealth Technology BioSyngen Pte Ltd. focuses on the clinical and commercial transfer of immune-cell therapy technologies and products. The company was founded in 2016 and is headquartered in Singapore. | - |
| Frank Wang | M | - |
BioSyngen Pte Ltd.
BioSyngen Pte Ltd. Pharmaceuticals: MajorHealth Technology BioSyngen Pte Ltd. focuses on the clinical and commercial transfer of immune-cell therapy technologies and products. The company was founded in 2016 and is headquartered in Singapore. | - |
| Zhe Ren Wang | M | 40 | 3 Jahre | |
| Jiwei Wang | M | 37 | 4 Jahre | |
| Hongbing Yang | M | 55 | 4 Jahre | |
| Min MIn Qin | M | 66 | 4 Jahre | |
| Lei Fang | M | 41 | 4 Jahre | |
| Hu Li | M | 59 | 4 Jahre | |
| Feiyu Shen | M | - |
BioSyngen Pte Ltd.
BioSyngen Pte Ltd. Pharmaceuticals: MajorHealth Technology BioSyngen Pte Ltd. focuses on the clinical and commercial transfer of immune-cell therapy technologies and products. The company was founded in 2016 and is headquartered in Singapore. | - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Wai Sing Wong | M | - | 5 Jahre | |
| Yu Liang | M | 51 | - | |
| Robert Geoffrey Ryan | M | 65 | - | |
| Monica Maria Nunes | F | 55 | 9 Jahre | |
| Hai Jing Zhou | M | 47 | 11 Jahre | |
| Suet Yin Choi | F | 51 | - | |
| Chao Hong Hu | M | 58 | 4 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| China | 67 | 67,68% |
| Hong Kong | 20 | 20,20% |
| Bermuda | 7 | 7,07% |
| Singapur | 6 | 6,06% |
| Italien | 4 | 4,04% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Feng Mao Hua
- Persönliches Netzwerk
